Impacto de la profilaxis secundaria en el manejo de pacientes con urolitiasis de alto riesgo de recidiva

In a previous study, we showed our experience in a group of 54 patients with a high risk of urolithiasis recurrence, who were subjected to a complete metabolic evaluation. Aim: To report the evolution of these patients after 5 years of follow-up. Patients and Methods: All patients underwent a genera...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ossandón S,Enrique, Sepúlveda T,Francisco, Acevedo C,Cristián
Lenguaje:Spanish / Castilian
Publicado: Sociedad Médica de Santiago 2016
Materias:
Acceso en línea:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872016000600004
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:scielo:S0034-98872016000600004
record_format dspace
spelling oai:scielo:S0034-988720160006000042016-10-03Impacto de la profilaxis secundaria en el manejo de pacientes con urolitiasis de alto riesgo de recidivaOssandón S,EnriqueSepúlveda T,FranciscoAcevedo C,Cristián Recurrence Secondary Prevention Urolithiasis In a previous study, we showed our experience in a group of 54 patients with a high risk of urolithiasis recurrence, who were subjected to a complete metabolic evaluation. Aim: To report the evolution of these patients after 5 years of follow-up. Patients and Methods: All patients underwent a general management of urolithiasis plus specific treatments for underlying metabolic disorders. Each patient had an annual medical assessment including a clinical examination, urinalysis and imaging studies (non-enhanced computed tomography scan, ultrasonography and plain abdominal Rx rays). In every case, the underlying metabolic disorder, treatment adherence, stones on imaging studies and symptomatology were evaluated. Adherence of general and specific measures were evaluated subjectively. Failure of secondary prevention was defined as the recurrence of clinical or imaging urolithiasis (increase of the number of lithiasis) despite a correct treatment of the metabolic disorders. Results: Twenty nine patients completed the follow-up. Mean age was 45 years old. Nineteen patients (65%) had only one metabolic disorder, three patients (10%) two disorders, one patient (3%) four disorders, and six patients (21%) a normal metabolic study. The median of follow-up was 54 months (45-60). During that period, twenty-three patients (79%) kept the treatment as it was indicated. In this subgroup, 21 had no clinical or imaging recurrence of urolithiasis during follow-up (91%). Total adherence to treatment and follow-up was 42% (23/54) of the initial group of patients. Conclusions: A complete metabolic study allows to identify patients with a high risk of urolithiasis recurrence, enabling a specific treatment of the metabolic disorder. Our experience shows that 75% (21/29) of patients remain free of recurrence at five years of follow-up.info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.144 n.6 20162016-06-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872016000600004es10.4067/S0034-98872016000600004
institution Scielo Chile
collection Scielo Chile
language Spanish / Castilian
topic Recurrence
Secondary Prevention
Urolithiasis
spellingShingle Recurrence
Secondary Prevention
Urolithiasis
Ossandón S,Enrique
Sepúlveda T,Francisco
Acevedo C,Cristián
Impacto de la profilaxis secundaria en el manejo de pacientes con urolitiasis de alto riesgo de recidiva
description In a previous study, we showed our experience in a group of 54 patients with a high risk of urolithiasis recurrence, who were subjected to a complete metabolic evaluation. Aim: To report the evolution of these patients after 5 years of follow-up. Patients and Methods: All patients underwent a general management of urolithiasis plus specific treatments for underlying metabolic disorders. Each patient had an annual medical assessment including a clinical examination, urinalysis and imaging studies (non-enhanced computed tomography scan, ultrasonography and plain abdominal Rx rays). In every case, the underlying metabolic disorder, treatment adherence, stones on imaging studies and symptomatology were evaluated. Adherence of general and specific measures were evaluated subjectively. Failure of secondary prevention was defined as the recurrence of clinical or imaging urolithiasis (increase of the number of lithiasis) despite a correct treatment of the metabolic disorders. Results: Twenty nine patients completed the follow-up. Mean age was 45 years old. Nineteen patients (65%) had only one metabolic disorder, three patients (10%) two disorders, one patient (3%) four disorders, and six patients (21%) a normal metabolic study. The median of follow-up was 54 months (45-60). During that period, twenty-three patients (79%) kept the treatment as it was indicated. In this subgroup, 21 had no clinical or imaging recurrence of urolithiasis during follow-up (91%). Total adherence to treatment and follow-up was 42% (23/54) of the initial group of patients. Conclusions: A complete metabolic study allows to identify patients with a high risk of urolithiasis recurrence, enabling a specific treatment of the metabolic disorder. Our experience shows that 75% (21/29) of patients remain free of recurrence at five years of follow-up.
author Ossandón S,Enrique
Sepúlveda T,Francisco
Acevedo C,Cristián
author_facet Ossandón S,Enrique
Sepúlveda T,Francisco
Acevedo C,Cristián
author_sort Ossandón S,Enrique
title Impacto de la profilaxis secundaria en el manejo de pacientes con urolitiasis de alto riesgo de recidiva
title_short Impacto de la profilaxis secundaria en el manejo de pacientes con urolitiasis de alto riesgo de recidiva
title_full Impacto de la profilaxis secundaria en el manejo de pacientes con urolitiasis de alto riesgo de recidiva
title_fullStr Impacto de la profilaxis secundaria en el manejo de pacientes con urolitiasis de alto riesgo de recidiva
title_full_unstemmed Impacto de la profilaxis secundaria en el manejo de pacientes con urolitiasis de alto riesgo de recidiva
title_sort impacto de la profilaxis secundaria en el manejo de pacientes con urolitiasis de alto riesgo de recidiva
publisher Sociedad Médica de Santiago
publishDate 2016
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872016000600004
work_keys_str_mv AT ossandonsenrique impactodelaprofilaxissecundariaenelmanejodepacientesconurolitiasisdealtoriesgoderecidiva
AT sepulvedatfrancisco impactodelaprofilaxissecundariaenelmanejodepacientesconurolitiasisdealtoriesgoderecidiva
AT acevedoccristian impactodelaprofilaxissecundariaenelmanejodepacientesconurolitiasisdealtoriesgoderecidiva
_version_ 1718436887224385536